DYAX: Dyax Corp. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : DYAX: Dyax Corp.

DYAX 38.41

0.0%

Jan 25 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: scaram(o)uche	1/25/2007 11:09:56 AM
	of 197

yahoo.reuters.com German Bayer ends three Trasylol clinical studies Thu Jan 25, 2007 10:28am ET FRANKFURT, Jan 25 (Reuters) - German drugmaker Bayer (BAYG.DE: Quote, Profile , Research) said on Thursday it has stopped three clinical studies for its heart-surgery drug Trasylol. The studies were to investigate the safety and efficacy of Trasylol on transfusion requirements and blood loss in adults undergoing spinal fusion surgery, pneumonectomy or esophagectomy for cancer, and total cystectomy in bladder cancer. Bayer said in a statement the decision to stop these trials was not made based on any safety findings. Bayer shares fell 2.1 percent to 43.25 euros by 1526 GMT.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next